(Press-News.org) Tokyo Institute of Technology (Tokyo Tech) Global Scientific Information and Computing Center (GSIC) and Hewlett Packard Enterprise (NYSE: HPE) announced to build its next-generation supercomputer, TSUBAME4.0, to accelerate AI-driven scientific discovery in medicine, materials science, climate research, and turbulence in urban environments.
Tokyo Tech is one of the world's leading universities in science and technology. With the TSUBAME4.0 supercomputer, users will have the ability to train more AI models and run applications in computational science and analytics, simultaneously, to augment research efforts and improve productivity.
TSUBAME4.0, which was procured under the Japanese government procurement rules and was
awarded to HPE Japan, will be fully operational in spring of 2024. The system will be based in a newly constructed facility in Tokyo Tech's Suzukakedai campus.
TSUBAME4.0 will be built using HPE Cray XD6500 supercomputers, which provide maximum performance and specialized capabilities to run modeling and simulation workloads required for complex scientific research. The HPE Cray XD6500 supercomputers are also highly dense and purpose-built to support accelerated compute that is optimized to power AI, analytics, and image-intensive applications.
"TSUBAME has been supporting our research on cyclic peptide drug discovery, which is anticipated to become the next-generation medicine," said Professor Yutaka Akiyama, School of Computing, Tokyo Tech. "TSUBAME has always been our partner in the daring challenges of achieving world's first. It has been supporting reproduction of biophysical phenomena with hundred-fold larger simulations, and through exhaustive calculation on hundreds of cases has generated quantitative proof of predictive ability. With the significantly accelerated TSUBAME4.0, we look forward to its support in realizing intelligent drug discovery through large-scale molecular simulation and fusing it with deep learning technology in generating predictive models."
TSUBAME4.0 will achieve a theoretical peak performance of 66.8 petaflops at 64-bit double precision. Additionally, the system will reach 952 petaflops at 16-bit half-precision, delivering 20 times more accelerated compute performance than TSUBAME3.0, its predecessor. TSUBAME4.0 will provide significantly higher performance to address the computational demands of many users, serving as a "supercomputer for everyone."
"National research centers across the globe rely on supercomputing to drive science, engineering, and AI initiatives to understand complex phenomena and accelerate innovation," said Justin Hotard, executive vice president and general manager, HPC, AI & Labs, at HPE. "Tokyo Tech is a powerful example of an organization that continues to invest in supercomputing and opens it to a broader community to enable cutting-edge research and new capabilities in AI. We are proud to continue our collaboration with Tokyo Tech and NVIDIA to build TSUBAME4.0, which features HPE Cray supercomputing innovation to deliver the massive performance required to augment Tokyo Tech's ongoing scientific and AI-driven missions."
Since the launch of TSUBAME1.0 in April 2006, the TSUBAME supercomputers have provided computing resources to global industry, academia, and government organizations as "everyone's supercomputer". GSIC of Tokyo Tech is the first university to adopt GPU-enabled supercomputers1, has gained recognition for delivering one of the most advanced, cutting-edge supercomputer centers in the world.
About TSUBAME4.0
"NVIDIA's computing platform drives acceleration at every scale for AI and HPC," said Ian Buck, vice president of HPC and Hyperscale Computing, NVIDIA. "Tokyo Tech's TSUBAME4.0 supercomputer, powered by NVIDIA H100 GPUs, NVIDIA Quantum-2 InfiniBand and our AI and HPC software, will empower researchers and scientists to tackle some of the world's most complex challenges and drive breakthroughs that can benefit society as a whole."
The TSUBAME4.0 configuration is similar to the existing TSUBAME series, which involves the x86_64 CPUs and CUDA compatible GPUs. This will enable the continued use of existing program assets and the fast-paced adoption of cutting-edge computational science and technology.
TSUBAME4.0 will be built with 30 HPE Cray XD6500 supercomputers equipped with two 3rd Gen AMD EPYC™ 9654 processors, four NVIDIA H100 Tensor Core GPUs, and 768 GiB of main memory. The storage system will consist of the Cray ClusterStor E1000, connected by a Lustre file system with 44.2PB of hard disk-based shared storage, and 327TB of SSD-based high-speed storage. Each compute node is also equipped with 1.92TB of NVMe-compatible high-speed SSD storage. The compute nodes and storage system will be connected to a high-speed network, and directly connected to the Suzukakedai's campus' network at a speed of 100 Gbps via SINET6.
Tokyo Tech supercomputer TSUBAME3.0 scheduled to start operating in summer 2017 | Tokyo Tech News
TSUBAME-KFC/DL supercomputer ranked No.2 in the world in Nov. 2015 edition of the energy efficiency Green500 List | Tokyo Tech News
TSUBAME 2.0 Upgraded to TSUBAME 2.5: Aiming Ever Higher | Research Stories
Global Scientific Information and Computing Center (GSIC)
###
About Tokyo Institute of Technology
Tokyo Tech stands at the forefront of research and higher education as the leading university for science and technology in Japan. Tokyo Tech researchers excel in fields ranging from materials science to biology, computer science, and physics. Founded in 1881, Tokyo Tech hosts over 10,000 undergraduate and graduate students per year, who develop into scientific leaders and some of the most sought-after engineers in industry. Embodying the Japanese philosophy of “monotsukuri,” meaning “technical ingenuity and innovation,” the Tokyo Tech community strives to contribute to society through high-impact research. https://www.titech.ac.jp/english/
About Hewlett Packard Enterprise
Hewlett Packard Enterprise (NYSE: HPE) is the global edge-to-cloud company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way people live and work, HPE delivers unique, open and intelligent technology solutions as a service. With offerings spanning Cloud Services, Compute, High Performance Computing & AI, Intelligent Edge, Software, and Storage, HPE provides a consistent experience across all clouds and edges, helping customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com
END
Tokyo Tech and HPE collaborate to build the next generation TSUBAME4.0 supercomputer for artificial intelligence, scientific research, and innovation
2023-05-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Heart attack patients with strong legs have better prognosis
2023-05-20
Prague, Czechia – 20 May 2023: People with strong legs are less likely to develop heart failure after a heart attack, according to research presented today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC).1
Myocardial infarction is the most common cause of heart failure,2 with around 6–9% of heart attack patients going on to develop the condition.3,4 Previous research has shown that having strong quadriceps is associated with a lower risk of death in patients with coronary artery disease.5
This study tested ...
Remote monitoring reduces heart failure hospitalizations and improves quality of life
2023-05-20
Prague, Czechia – 20 May 2023: The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it improves quality of life and reduces heart failure hospitalisations in patients with chronic heart failure. The findings are presented today in a late breaking science session at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in The Lancet.
Principal investigator Dr. Jasper Brugts of Erasmus University Medical Centre, ...
A Spanish team presents the first pharmacological treatment able to improve cardiac function in stiff-heart syndrome
2023-05-20
Transthyretin-related cardiac amyloidosis is a progressive disease characterized by the deposition of amyloid protein fibrils in the heart. Amyloid fibril deposition thickens and stiffens the heart walls, and the disease is also known as stiff-heart syndrome. The accumulation of amyloid fibrils causes heart failure, and patients suffer from fluid retention, fatigue, and arrhythmias. The disease can be caused by genetic mutations or related to aging. Prognosis is poor, and untreated patients survive for an average of just 3 years.
Now, the ...
George Dangas, MD, Ph.D., named President of Society for Cardiovascular Angiography & Interventions
2023-05-20
The Society for Cardiovascular Angiography & Interventions (SCAI) has named George Dangas, MD, PhD, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai as its new President. He was appointed on Saturday, May 20, during the closing ceremonies at the SCAI 2023 Scientific Sessions in Phoenix. He is the first Mount Sinai cardiologist to hold this position and will serve as the 46th President of SCAI.
Dr. Dangas, also the Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology ...
Forging partnerships in the Americas: Naval leaders gather at SIANC S&T Conference
2023-05-20
ARLINGTON, Va.—For Dr. Brett Seidle — the deputy assistant secretary of the Navy for Research, Development, Test and Engineering — the breakneck speed of current scientific progress and technological proliferation can be challenging, especially when the impact of new technologies on civilian and military realities transcends national borders.
While giving the keynote address at the recent Specialized Inter-American Naval Conference on Science, Technology and Innovation (SIANC-ST&I) in Orlando, Florida, Seidle identified several scientific disciplines that have developed into ...
New study reveals possible future health impacts related to climate mitigation
2023-05-20
UNIVERSITY PARK, Pa. — Reduce fossil fuel use and air quality will improve, right? It might not be as straightforward as it appears, according to a Penn State-led research team. They explored almost 30,000 simulated future scenarios and found that some climate mitigation efforts could lead to harmful health impacts in certain geographic areas.
Their results were published today (May 18) in Nature Sustainability.
“In general, reducing fossil fuel use is good for climate mitigation and good for cleaning up the air, and the modeling studies have always found health benefits from climate mitigation,” said corresponding ...
Study finds cardiovascular risk score improves after one year of semaglutide use in patients with overweight and obesity
2023-05-20
New research presented at this year’s European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use. The study is by Dr Andres Acosta and Dr Wissam Ghusn, Precision Medicine for Obesity Program at the Mayo Clinic, Rochester, MN, USA and colleagues.
Obesity is a major risk factor for the development of abnormal blood fat levels, type-2 diabetes mellitus (T2DM), high blood pressure, and obstructive sleep apnoea. These comorbidities are associated with an increased risk of cardiovascular disease (CVD) that represents ...
Semaglutide shown to be effective for weight loss in multicentre, one-year real-world study
2023-05-20
New research presented at this year’s European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study. The study is by Dr Andres Acosta and Dr Wissam Ghusn, Precision Medicine for Obesity Program at the Mayo Clinic, Rochester, MN, USA and colleagues.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the most recently FDA-approved anti-obesity medication. It has shown significant weight loss outcomes in multiple long-term randomised clinical trials and short-term real-world studies. However, little is known about ...
Consequences of uncontrolled hunger in teenagers living with obesity examined in international study
2023-05-20
Teenagers living with obesity who say hunger is preventing them from losing weight (hunger-barrier ALwO) perceive their weight more negatively and worry about it more than youngsters who don’t see hunger as an obstacle, new research being presented at the European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May) shows.
The international study also found that hunger-barrier ALwO are more likely to be female and more likely to say their weight makes them unhappy and leads to them being bullied. They are also more likely to be actively trying to lose weight.
Dr Bassam Bin-Abbas, of the Department of Paediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, ...
Stress hormone measured in hair predicts who is likely to suffer from cardiovascular diseases
2023-05-20
New research being presented at this year’s European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May) suggests that glucocorticoid levels (a class of steroid hormones secreted as a response to stress) present in the hair of individuals may indicate which of them are more likely to suffer from cardiovascular diseases (CVD) in the future.
“There is a tremendous amount of evidence that chronic stress is a serious factor in determining overall health. Now our findings indicate that people with higher long-term hair glucocorticoid ...